For instance, in vitro studies using HepG2 cells treated with palmitic acid revealed that the GLP-1RA exendin-4 downregulated the expression of SREBP-1c and FAS, thereby attenuating steatosis (14, 15)
But I'm going to do the test and see
Weight Reduction Observations A 2025 network meta-analysis published in the Journal of the Endocrine Society compared data from separate clinical trials: A systematic review examining multiple agents reported: Tirzepatide (15 mg): Up to 17.8% weight reduction from baseline Retatrutide (12 mg): Up to 24.2% weight reduction from baseline Semaglutide (2.4 mg): Up to 14% weight reduction for reference Phase 2 Trial Results: Retatrutide Published in the New England Journal of Medicine, the Phase 2 trial of retatrutide in adults with obesity showed dose-dependent reductions in body weight of up to 24% after 48 weeks of treatment
Primary outcomes were myocardial infarction (MI), pulmonary embolism (PE), coronary revascularization, transient ischemic attack (TIA) or stroke, and venous thromboembolism (VTE)
NAC pairs with milk thistle through 2 different liver mechanisms
Why Might You Stop Taking Semaglutide